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1. About the special issue 
This special issue presents several systematic reviews of the poten-
tial human health effects associated with exposure to phthalates and 
addresses some of the considerations and challenges that were en-
countered over the course of performing these reviews. This editorial 
presents the views of the lead U.S. Environmental Protection Agency 
(EPA) researchers on the project and the Special Issue Editors with 
regard to lessons learned, implications of methods, and the path for-
ward for systematic reviews to support human health assessment. 
Phthalates comprise a class of alkyl diesters of phthalic acid and are 
used in a variety of consumer products including cosmetics, personal 
care, pharmaceuticals, medical devices, children’s toys, food packaging, 
and cleaning and building materials. Owing to this widespread use, 
human exposure to phthalates is ubiquitous across all life stages, in-
cluding during gestation and early postnatal life (CPSC, 2014; NRC, 
2008). There is a considerable body of evidence demonstrating that 
certain phthalates can disrupt male reproductive development through 
the inhibition of testosterone production as well as through mechan-
isms that are independent of the antiandrogenic effects (Foster and 
Gray, 2013; CPSC, 2014; NRC, 2008); therefore, recent assessments of 
phthalate toxicity have generally centered on male reproductive effects. 
A 2017 systematic review of the low dose toxicity of phthalates by the 
National Academy of Sciences (NAS) focused exclusively on three an-
drogen-dependent male reproductive endpoints (testosterone mea-
surements, anogenital distance, and hypospadias) that are known to be 
sensitive to phthalate exposure (NAS, 2017). Antiandrogenic activity 
was also the basis for the US Consumer Product Safety Commission 
(CPSC) rule to permanently ban certain phthalates at any amount 
greater than 0.1% in children’s toys and childcare articles, which was 
expanded in 2017 to include additional phthalates that share this mode 
of action (CPSC, 2017). 
The work described in this Special Issue was designed to char-
acterize the range of health outcomes associated with exposure to 
phthalates, including emerging health outcomes that were not covered 
by recent reports, and consists of six systematic review papers and three 
methodology papers. Systematic reviews of epidemiology studies were 
conducted for six phthalates (DEHP, DBP, BBP, DINP, DIBP, DEP) and 
are reported in four papers that describe associations of these chemicals 
with male reproductive effects (Radke et al., 2018), female 
reproductive and developmental effects (Radke et al., 2019a), meta-
bolic effects (Radke et al., 2019b), and neurodevelopmental effects 
(Radke et al., 2020). Systematic reviews of experimental animal studies 
were conducted for DIBP (Yost et al., 2019) and DEP (Weaver et al., 
accepted for publication), with each paper describing the evidence for 
six major health outcome categories: male reproductive, female re-
productive, developmental, liver, kidney, and cancer. The methodology 
papers address issues encountered during the course of conducting 
these reviews that will be of broad applicability to practitioners of 
systematic review in environmental health, including the evaluation of 
epidemiological studies using outcome-specific assessment criteria 
(Radke et al., 2019c) and the evaluation of animal studies for reporting 
quality, risk of bias, and sensitivity (Dishaw et al., accepted for pub-
lication). Lastly, Blessinger et al. (2020) present an ordinal dose–r-
esponse model that addresses the challenges of modeling the collection 
of endpoints that characterize “phthalate syndrome” in experimental 
animal studies. 
We believe this experience in applying systematic review methods 
to a large, complex evidence base will be informative for others in the 
field. Systematic review is being increasingly recognized by research 
and regulatory organizations as the gold standard for chemical risk 
assessment. Many of the benefits of systematic review, as well as the 
major advances and challenges facing researchers in this field, are il-
lustrated in the July 2016 Environment International Special Issue, 
“Systematic Review Methods for Advancing Chemical Risk Assessment” 
(Whaley and Halsall 2016). Advantages of this approach include 
transparency and objectivity. However, challenges remain, including 
how to make systematic review pragmatic when applied to the broad 
topic areas encountered in environmental health. The methodologies 
for study selection, study evaluation, and evidence synthesis described 
in this set of papers were developed for use in the EPA’s Integrated Risk 
Information System (IRIS) assessments to address some of these chal-
lenges, but these papers are among the first publicly available reviews 
using the methodologies. It is important to note that the IRIS approach 
described in the systematic review protocol for these reviews has 
evolved since their development and it is expected this evolution will 
continue over time as methodologies advance and feedback is received 
from the scientific community. Recently posted protocols reflect the 
current IRIS approach and are available at https://www.epa.gov/iris/ 
iris-recent-additions. 
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2. Challenges and lessons learned 
There are several scientific issues that cut across multiple papers in 
this special issue, which will be discussed here. This includes the use of 
a novel study evaluation framework to evaluate reporting quality, risk 
of bias, and sensitivity, and the use of expert judgment in critical ap-
praisal of individual studies (study evaluation) and the overall body of 
evidence. Specific considerations for epidemiology and experimental 
animal evidence of phthalate exposure are also described below. 
2.1. Critical appraisal of evidence 
All of the reviews of health effects of phthalates in human and an-
imal studies (Radke et al., 2018, 2019a, 2019b, 2020; Yost et al. 2019; 
Weaver et al., accepted for publication) use the same general approach 
for study evaluation and evidence synthesis, though specific con-
siderations vary between the disciplines. For each of the stages of the 
systematic review, the protocol (available in the supplemental mate-
rials for each review) describes the considerations that inform expert 
judgments on the evidence. For study evaluation, this consists of core 
and prompting questions, as well as specific considerations for reaching 
a rating for each evaluation domain (Tables 4 and 5 in the protocol). 
Greater detail on study evaluation is provided in publications in this 
special issue: Radke et al. (2019c) for epidemiology studies and Dishaw 
et al. (accepted for publication) for animal studies. For evidence 
synthesis, the primary considerations are adapted from Bradford Hill’s 
considerations for causality (Tables 10 and 11 in the protocol). These 
considerations are then used together to reach an overall judgment of 
the evidence using a structured framework (Tables 12 and 13 in the 
protocol). This framework is conceptually similar to and is informed by 
the well-established Grading of Recommendations, Assessment, Devel-
opment and Evaluations (GRADE) approach, but is designed to address 
challenges specific to the analysis of environmental health data rather 
than clinical evidence. 
During peer review, there were some concerns that the criteria for 
reaching the different levels of confidence (within or across studies) 
were too reliant on expert judgment without clear constraints on that 
judgment. Without clear, consistent criteria, there is a risk of poor 
transparency for the decisions made in the systematic review. The ap-
proach used in these reviews was intentionally designed to rely on 
expert judgment rather than prescriptive criteria, pre-defined weights, 
or strict up/downgrading on the premise that experts are best equipped 
to make decisions on complex issues; however, but the peer review 
feedback highlighted the need to improve transparency and limit the 
potential for excess subjectivity. All of the review decisions are docu-
mented either within the publication or in linked materials (e.g., ra-
tionales for study evaluations are available in Health Assessment 
Workspace Collaborative (HAWC), a free and open source web-based 
software application, available at https://hawcprd.epa.gov/portal/). 
For all systematic reviews, there is a tension in the amount of constraint 
on expert judgment, and this will be worked on in refining this balance 
in future reviews. 
Reviewers also commented on the unusual approach of separately 
evaluating reporting quality, risk of bias, and sensitivity in animal 
studies, which is different from the approach taken in other common 
study evaluation tools such as. the Navigation Guide, which rates nei-
ther reporting quality nor study sensitivity in assessing the evidence, 
and the National Toxicology Program’s Office of Health Assessment and 
Translation (OHAT) risk of bias tool (NTP, 2015), which does not rate 
reporting quality. The reason the IRIS approach employs sensitivity as 
an assessment domain is that systematic review community has strug-
gled with how to capture certain aspects of study design that do not 
strictly fall under risk of bias, which is defined as “a systematic error, or 
deviation from the truth, in results or inferences”. For example, a study 
could have been conducted in a way that is bias-free but looked at an 
insensitive period of exposure. Some tools include these in the risk of 
bias metrics, but the IRIS approach attempts to be more explicit in la-
beling them as “sensitivity” related. The IRIS “reporting quality” do-
main looks at whether a study has reported sufficient details to conduct 
a risk of bias and sensitivity analysis; studies that do not report basic 
information such as species and test compound may be excluded. The 
present view is this approach improves the transparency of the eva-
luation. 
2.2. Epidemiology evidence 
There are several phthalate-specific considerations for evaluating 
epidemiology evidence in these reviews, and these are described below. 
All are relevant to the four systematic reviews of epidemiology data 
(Radke et al., 2018, 2019a, 2019b, 2020). 
2.2.1. Phthalate-specific study evaluation criteria for exposure 
measurement 
The majority of epidemiology studies of phthalates are based on 
measurement of phthalate metabolite levels. An important considera-
tion in the evaluation of these biomarkers is the matrix or tissue from 
which they are measured. Phthalate metabolite concentration in urine 
is considered to be the best proxy of exposure from all sources (in-
gested, dermally absorbed, inhaled). One problem with measurement in 
blood and other tissues is the potential for contamination from outside 
sources (Calafat et al. 2015). Phthalate diesters present from exogenous 
contamination can be metabolized to the monoester metabolites by 
enzymes present in blood and other tissues, but not urine. For this 
reason, studies using biomarker measurements in samples other than 
urine for the monoester metabolites (e.g. MEHP) were excluded from 
the systematic reviews. For secondary metabolites of long-chain 
phthalates (i.e. DEHP and DINP), which are not influenced by this issue, 
studies were considered low confidence when samples other than urine 
were used. 
Another consideration in the measurement of phthalate exposure is 
the short half-life of phthalate metabolites in the body (ranging from 
approximately 3 to < 24 h). Exposure can vary by time of day as well as 
over time. The short-term (1–12 weeks) reliability of metabolite mea-
sures, measured by the intraclass correlation coefficient is approxi-
mately 0.3–0.6 for the shorter chain metabolites (DBP, DIBP, BBP, and 
DEP) and 0.1–0.3 for the long-chain phthalates (DEHP and DINP) 
(Johns et al., 2016). Thus, particularly for the long-chain phthalates, 
the use of a single sample is expected to introduce nondifferential ex-
posure misclassification. More samples are needed to measure exposure 
to the long-chain phthalates with sufficient precision, and this is re-
flected in the study evaluations. However, given that the nondifferential 
misclassification is likely to bias results towards the null, this issue 
should not reduce confidence in observed associations with health ef-
fects. 
Additional discussion of these exposure measurement issues as well 
as specific criteria are described in the systematic review protocol, 
available as supplemental material to each of the systematic reviews. 
2.2.2. Potential confounding across phthalates 
Since different phthalates may be used in similar applications, po-
tential confounding among phthalates is another important considera-
tion. Several phthalates have moderate correlations with each other in 
human urine. When results are similar for two moderately (or higher) 
correlated phthalates in a study, confounding by other phthalate ex-
posure should be considered as a possible explanation. An ideal study 
would have accounted for this in its analysis, but this is still relatively 
uncommon and not always possible due to collinearity and other ana-
lytic issues. Rather than rating each study with lower confidence due to 
this issue, it was considered it an area of uncertainty for all of the 
conclusions about associations between individual phthalates and 
health effects. 
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2.2.3. Coherence of effects across phthalates 
In addition to drawing conclusions for each phthalate-outcome pair, 
there is interest in analyzing coherence of effects across phthalates. This 
would inform conclusions about the effects of the total mixture of 
phthalates to which people are exposed as well as individual phthalates 
(i.e., coherence across phthalates would increase confidence in the ef-
fect). Unfortunately, available data made it challenging to evaluate this 
coherence. It was expected that the most similar phthalate pairs (i.e., 
DEHP/DINP and DBP/DIBP) would also have the most coherent evi-
dence of effects, and this was generally not the case. However, for both 
pairs, the database for one phthalate (DINP and DIBP) was less sensitive 
due to the number of studies and lower exposure levels, which could 
explain the weaker evidence. Because of this limitation, coherence was 
difficult to assess. 
2.2.4. Prioritizing outcomes for systematic review 
There are 25 outcomes included in the epidemiology systematic 
reviews, totaling 150 phthalate-outcome pairs. However, this does not 
include every outcome that has been studied in the literature (75+). 
Due to resource constraints, there was a need to be pragmatic in the 
outcomes undergoing full systematic review. In addition, even with 
unlimited resources, there are outcomes where either the limitations of 
the evidence are so severe or the evidence so inadequate that there is 
little value in pursuing a review. The paper on metabolic effects (Radke 
et al., 2019c) provides an example of a “screening level” review that 
identified such outcomes (obesity and renal effects). In other cases, 
outcomes were dropped from further review due to inadequate data 
(cancer, hepatic and respiratory effects). Lastly, systematic reviews 
were planned for some additional effects (immune and thyroid) but 
were not completed due to available resources. A new approach, sys-
tematic evidence mapping (described in Wolffe et al., 2019), is now 
being used in the IRIS program for this type of scoping/prioritization 
exercise and is discussed further below. 
2.2.5. Outcome-specific study evaluation criteria 
Another consequence of the number of outcomes in the database 
was the need for outcome-specific criteria for study evaluation. It was 
not possible for the epidemiologists performing the reviews to be ex-
perts in every outcome. Therefore, a process of subject matter expert 
consultation was undertaken, and this is described in Radke et al. 
(2019c). The criteria developed as a result of this process are chemical 
agnostic, and thus can be adapted for future systematic reviews. 
2.3. Experimental animal evidence 
Cross-cutting issues encountered in the systematic review of ex-
perimental animal evidence are described below. 
2.3.1. Using PECO to define outcomes for systematic review 
Literature screening and the selection of relevant studies was guided 
by a PECO (Populations, Exposures, Comparators, Outcomes) state-
ment, which was included in the systematic review protocol. Whereas 
the PECO for human studies included any examination of human health 
effects associated with phthalate exposure, the PECO for animal studies 
specified that the systematic reviews would focus on six broad outcome 
categories: male reproductive, female reproductive, developmental, 
liver, kidney, and cancer. These six categories were identified in a 
preliminary review of the literature as being commonly associated with 
phthalate exposure and were selected as a pragmatic approach to focus 
the evaluation on outcomes that were likely to have more data avail-
able. Indeed, as described in Yost et al. (2019) and Weaver et al. (ac-
cepted for publication), the systematic reviews of animal studies iden-
tified very few studies that evaluated outcomes other than those 
included in the PECO, and if other outcomes had been included it is 
unlikely that there would have been enough data available to draw 
conclusions. Thus, although the process for selecting these six outcomes 
was relatively informal, it helped to streamline the systematic reviews 
of DIBP and DEP and likely had minimal impact on the overall con-
clusions. Nevertheless, this approach runs the risk of missing potentially 
important health outcomes, and multiple reviewers called for increased 
transparency regarding how outcomes were selected for inclusion in the 
PECO. It is therefore recommended that systematic evidence mapping 
be employed as a more formal approach for outcome selection in future 
systematic reviews. Systematic evidence mapping has emerged as a 
methodology for identifying the amount and type of evidence available 
to address a particular topic (e.g. Miake-Lye et al., 2016; Wolffe et al., 
2019), and can be used as a step during problem formulation in order to 
identify health outcomes that warrant a full systematic review. 
2.3.2. Chemical- and outcome-specific considerations for animal study 
evaluation 
Few phthalate-specific considerations were necessary for the eva-
luation of animal studies; the concerns about biomarker measurements 
and confounding of effects across phthalates described for human stu-
dies are not applicable to animal studies, which (as specified in the 
PECO) exposed animals to singular phthalates at a nominal dose. 
However, as with human studies, it was often necessary to develop 
outcome-specific considerations for animal study evaluation. Dishaw 
et al. (accepted for publication) provides examples of specific con-
siderations for the evaluation of male reproductive outcomes, which 
were among the major outcomes evaluated in the DIBP and DEP animal 
studies. 
2.3.3. Integration of mechanistic evidence 
The benefits and challenges of incorporating mechanistic evidence 
into a systematic review is an emerging area of interest in the field of 
risk assessment. Although a full evaluation of mechanistic data was not 
performed in the systematic reviews of DIBP and DEP, relevant me-
chanistic data was used to augment the qualitative synthesis. For in-
stance, multiple studies that evaluated testosterone levels in rats or 
mice also reported on testicular expression of genes or proteins in-
volved in cholesterol homeostasis and steroidogenesis. The inclusion of 
these data in the qualitative synthesis supports observations of the ef-
fects (or lack thereof) of these phthalates on testicular steroidogenesis 
and provides insight into the potential mechanism. 
While it is beyond the scope of these systematic reviews, integration 
across human and animal lines of evidence for phthalates would benefit 
from a more thorough evaluation of mechanistic data. As stated in their 
review of the EPA’s IRIS process, the National Academies of Sciences, 
Engineering, and Medicine (2014) stated that, “When human data are 
nonexistent, are mixed, or consistently show no association and an 
animal study finds a positive association, the importance of mechanistic 
data is increased.” 
3. Conclusions and path forward 
The work in this special issue addresses two main research areas: the 
effects of phthalate exposure on health and the application of sys-
tematic review methods to broad, complex health assessments. 
Regarding the first, this is the largest and most comprehensive analysis 
of the health effects of phthalates published to date. Other reviews have 
focused more narrowly on certain health outcomes or used non-sys-
tematic methodology. Given the ubiquity of phthalate exposure in to-
day’s society, there is a critical need to understand what that exposure 
means for people across all life stages. It is clear from these reviews that 
male reproductive effects are a hazard of phthalate exposure (Radke 
et al., 2018; Yost et al., 2019), consistent with past reviews, with the 
interesting observation that exposure to DEP (not generally considered 
a male reproductive toxicant) may lead to effects on sperm independent 
of androgenic effects (Weaver et al., accepted for publication). The 
review of animal studies also supports previous observations that DIBP 
is a more potent developmental toxicant than DEP and highlighted 
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some potential female reproductive effects of DIBP exposure (Yost 
et al., 2019; Weaver et al., accepted for publication). There is also 
strong evidence of associations with preterm birth (Radke et al., 2019a) 
and diabetes and insulin resistance (Radke et al., 2019b), which has not 
been established previously. In addition, these reviews indicated some 
areas where the evidence is not as strong as may be commonly believed. 
The evidence for an association with neurodevelopment was largely 
inconsistent without a clear pattern of association (Radke et al., 2020), 
and there are important data gaps that need to be filled before drawing 
any causal conclusions. 
A major limitation of the work described in this special issue is the 
lack of evidence integration across the evidence streams (i.e., human, 
animal, and mechanistic evidence). An integration approach is aimed at 
identifying how complementary but different evidence streams might 
be combined, yielding knowledge of the effects of an environmental 
exposure which might not be available if the evidence streams are 
analyzed in isolation from each other. For example, epidemiology and 
experimental animal studies complement each other in identifying 
health effects from exposures, as they each bring strengths that address 
key limitations in the other discipline (i.e., observational epidemiology 
studies provide evidence in humans, the species of interest, but do not 
allow for control of exposure; while experimental animal studies allow 
for precise and randomized control of exposure but effects in animals 
may not be directly relevant to humans). This is an important future 
step for the evidence of health effects resulting from phthalate exposure 
and could inform some of the limitations described in the systematic 
reviews, such as reducing concerns about confounding across phtha-
lates in the epidemiology studies. 
In addition, this was one of the first comprehensive attempts to use 
systematic review methods developed by the EPA’s IRIS program for the 
assessment of environmental chemicals. As a process, it has not been 
without its challenges. Systematic review methods were originally de-
veloped for confirmatory mode (Nosek et al., 2018) research projects 
posing only one or two questions or hypotheses. This is because ana-
lyzing existing evidence is both time-consuming and conceptually 
complex; reliably making sense of what existing research is saying in 
answer to a question has historically been considered feasible only for 
small bodies of evidence. Regulatory agencies such as EPA, however, 
have broader information demands than can be serviced by a focused 
systematic review, with questions about multiple exposure scenarios, 
populations of concern, and outcomes of interest needing to be ad-
dressed. The need to address multiple questions, and therefore syn-
thesize large bodies of evidence, presents a major challenge to im-
plementation of evidence synthesis methods in regulatory scenarios 
while remaining simultaneously systematic and timely. The reviews in 
this Special Issue are an attempt by IRIS scientists to achieve exactly 
this. 
While systematic methods produce the most reliable results when 
summarizing existing evidence, it is not necessarily the case that spe-
cifically conducting a systematic review is the most appropriate ap-
proach in any given scenario. As described above, in scenarios where 
the primary need is to scope the literature, systematic evidence map-
ping methods may be the more fit-for-purpose approach (James et al., 
2016). Evidence mapping can also be used to set priorities when a 
systematic review is required (Wolffe et al., 2019). For instance, in a 
regulatory scenario where there is suggestive evidence that a current 
exposure limit for a chemical may need to be revised, evidence mapping 
could be used to select the endpoints that are most likely to lead to a 
revision of the exposure limit, and full systematic review can then be 
conducted on those endpoints. 
Where complex systematic reviews are deemed to be necessary, 
suitable research infrastructure needs to be developed which can sup-
port projects requiring detailed yet wide-ranging analysis that allows 
them to be conducted in appropriate time-scales with sufficient accu-
racy. Such infrastructure would include pre-trained and identified pools 
of experts, methodological templates and chemical-agnostic processes, 
and fit-for-purpose tools which can be applied reasonably quickly with 
sufficient validity – to name a few. These would also include artificial 
intelligence-supported systems and suitable data storage approaches 
facilitating rapid extraction and reuse of the detailed scientific in-
formation required by systematic assessment methods (Wolffe et al., 
accepted for publication; Wittwehr et al., 2020). 
In conclusion, these reviews have improved our understanding of 
health effects of phthalate exposure, and lessons learned in the conduct 
of these reviews have informed the further development of systematic 
review methods in the IRIS program and may be relevant to human 
health risk assessments by other agencies. There are additional oppor-
tunities to improve acceptance of fit-for-purpose methods for this type 
of complex health assessment. 
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